Cargando…
Current and Innovative Approaches in the Treatment of Non-muscle Invasive Bladder Cancer: The Role of Transurethral Resection of Bladder Tumor and Organoids
BACKGROUND: Bladder cancer is the 7th most common cancer in men. About 75% of all bladder cancer are non-muscle invasive (NMIBC). The golden standard for definite diagnosis and first-line treatment of NMIBC is transurethral resection of bladder tumour (TURB). Historically, the monopolar current was...
Autores principales: | Taskovska, Milena, Kreft, Mateja Erdani, Smrkolj, Tomaz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Sciendo
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7276645/ https://www.ncbi.nlm.nih.gov/pubmed/32374292 http://dx.doi.org/10.2478/raon-2020-0025 |
Ejemplares similares
-
Detrimental Effect of Various Preparations of the Human Amniotic Membrane Homogenate on the 2D and 3D Bladder Cancer In vitro Models
por: Janev, Aleksandar, et al.
Publicado: (2021) -
The Role of Transurethral Resection in Trimodal Therapy for Muscle-Invasive Bladder Cancer
por: Russell, Christopher M., et al.
Publicado: (2016) -
Selective targeting of lectins and their macropinocytosis in urothelial tumours: translation from in vitro to ex vivo
por: Resnik, Nataša, et al.
Publicado: (2023) -
Transurethral resection of bladder tumor-based bladder preservation therapy for refractory high risk non-muscle invasive bladder cancer: Current landscape and future directions
por: Sun, Xinghui, et al.
Publicado: (2023) -
Multivariate Analysis of the Prognostic Significance of Resection Weight after Transurethral Resection of Bladder Tumor for Non-Muscle-Invasive Bladder Cancer
por: Kwon, Dae Hyeon, et al.
Publicado: (2012)